Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,984,613 papers from all fields of science
Search
Sign In
Create Free Account
Kurtzke Expanded Disability Status Scale Questionnaire
Known as:
EDSS
, EDSS01
A standardized rating scale developed by John F. Kurtzke in 1983 to measure the disability status and level of functioning in people with multiple…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
CDISC Questionnaire Category Terminology
Clinical Data Interchange Standards Consortium Terminology
Kurtzke multiple sclerosis rating scale
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
[Brain atrophy and perfusion changes in patients with remitting and secondary progressive multiple sclerosis].
I. Krotenkova
,
V. Bryukhov
,
M. Krotenkova
,
M. Zakharova
,
L. Askarova
Zhurnal Nevrologii i Psikhiatrii imeni S.S…
2018
Corpus ID: 52127800
AIM To study the relationship of brain atrophy and changes in perfusion with an increase in the level of disability in patients…
Expand
Review
2016
Review
2016
Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy
I. Fyfe
Nature Reviews Neurology
2016
Corpus ID: 23223440
for relapsing–remitting multiple sclerosis (MS) have long-term benefits in the real world, a new large registry cohort study has…
Expand
2015
2015
New imaging language skills required in MS
M. Sormani
,
N. Evangelou
Neurology
2015
Corpus ID: 1766888
One of the key problems in clinical research involving persons with multiple sclerosis (MS) is the moderate correlation between…
Expand
2014
2014
Outcome Measures in Multiple Sclerosis
R. Bermel
,
A. Waldman
,
E. Mowry
Multiple Sclerosis International
2014
Corpus ID: 5363923
The acquisition of a reliable and valid outcome measure in multiple sclerosis (MS) is one of the holy grails for clinician…
Expand
2012
2012
Physical disability and psychological distress in multiple sclerosis: the role of illness representations and experiential avoidance
J. Feeney
2012
Corpus ID: 141036478
Objectives: This study explores factors associated with psychological wellbeing and distress in people with Multiple Sclerosis…
Expand
2011
2011
Improving power to detect disease progression in multiple sclerosis through alternative analysis strategies
B. Healy
,
T. Chitnis
,
D. Engler
Journal of Neurology
2011
Corpus ID: 10569958
In patients with multiple sclerosis, investigation of a treatment effect on disease progression in clinical trials and…
Expand
2003
2003
Towards Environmental Decision Support Systems
U. Cortés
,
M. Sànchez-Marrè
,
I. R-Roda
,
M. Poch
2003
Corpus ID: 17420852
This is a position paper willing to fix concepts in the interface between Environmental Issues and Artificial Intelligence. In…
Expand
2001
2001
[Clinical course and changes of soluble interleukin-2 receptor and soluble forms of intercellular adhesion molecule-1 (ICAM-1) in serum of multiple sclerosis patients].
M. Bilińska
,
I. Frydecka
,
R. Podemski
Neurologia i Neurochirurgia Polska
2001
Corpus ID: 1288925
UNLABELLED Changes were assessed in serum levels of soluble interleukin-2 receptor (sIL-2R alpha) and soluble intercellular…
Expand
Review
1998
Review
1998
Rehabilitation principles for patients with multiple sclerosis.
G. Kraft
Journal of Spinal Cord Medicine (JSCM)
1998
Corpus ID: 34833872
The purpose of this review was to discuss some newer rehabilitation techniques and their applications in MS. There are a number…
Expand
1994
1994
Follow‐up study of MS patients treated with high‐dose intravenous methylprednisolone
S. Frequin
,
K. Lamers
,
F. Barkhof
,
G. Borm
,
O. Hommes
Acta Neurologica Scandinavica
1994
Corpus ID: 19718670
In a longitudinal prospective study, we followed 56 patients (17 men, 29 women) with definite multiple sclerosis (MS), who were…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE